2.4.0.8137 - Disclosure - Warrant Activity (Detail)truefalsefalse1false USDfalsefalse$eol_PE10315---1310-Q0011_STD_181_20130630_0_716763x715581http://www.sec.gov/CIK0001069308duration2013-01-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse1false USDtruefalse$eol_PE10315---1310-Q0011_STD_181_20130630_0_716763x715581http://www.sec.gov/CIK0001069308duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseWarrants Attached to Debtus-gaap_ClassOfWarrantOrRightAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_ClassOfWarrantOrRightAxisexplicitMembersharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Warrants Attached to Debt2true 4opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRollforwardAbstractopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Number of Shares3false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNumberopxa_falsenainstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse35790873579087falsefalsefalsexbrli:sharesItemTypesharesShare Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other than Options Outstanding, NumberNo definition available.false1Number of Shares, Outstanding at beginning of period4false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse972918972918falsefalsefalsexbrli:sharesItemTypesharesThe number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Number of Shares, Granted5false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00  falsefalsefalsexbrli:sharesItemTypesharesShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercises in PeriodNo definition available.false1Number of Shares, Exercised6false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-1482892-1482892falsefalsefalsexbrli:sharesItemTypesharesThe number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(3) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Number of Shares, Forfeited and canceled7false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNumberopxa_falsenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse30691133069113falsefalsefalsexbrli:sharesItemTypesharesShare Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other than Options Outstanding, NumberNo definition available.false1Number of Shares, Outstanding at end of period8false 5opxa_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumbersopxa_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse30691133069113falsefalsefalsexbrli:sharesItemTypesharesShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercisable NumbersNo definition available.false1Number of Shares, Exercisable at end of period9true 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Weighted average exercise price10false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceopxa_falsenainstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse5.645.64USD$falsetruefalsenum:perShareItemTypedecimalShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price, Outstanding at beginning of period11false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePriceopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2.212.21USD$falsetruefalsenum:perShareItemTypedecimalShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price, Granted12false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValueus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00  USD$falsefalsefalsenum:perShareItemTypedecimalWeighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(3) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false3Weighted average exercise price, Exercised13false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodWeightedAverageExercisePriceopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse6.546.54USD$falsetruefalsenum:perShareItemTypedecimalShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures in Period, Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price, Forfeited and canceled14false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceopxa_falsenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse4.124.12USD$falsetruefalsenum:perShareItemTypedecimalShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price, Outstanding at end of period15false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePriceopxa_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse4.124.12USD$falsetruefalsenum:perShareItemTypedecimalShare Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Other than Options, Exercisable, Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price, Exercisable at end of period16true 4opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageRemainingContractualTermAbstractopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Weighted average remaining contract term17false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse003 years 8 months 12 daysfalsefalsefalsexbrli:durationItemTypenaWeighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Weighted average remaining contract term, Outstanding at end of period18false 5opxa_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTermsopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse003 years 8 months 12 daysfalsefalsefalsexbrli:durationItemTypenaShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercisable, Weighted Average Remaining Contractual TermsNo definition available.false0Weighted average remaining contract term, Exercisable at end of period19true 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValueRollForwardus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Intrinsic Value20false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValueExpectedToVestExercisableAggregateIntrinsicValueopxa_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse130688130688USD$falsetruefalsexbrli:monetaryItemTypemonetaryShare based Compensation Arrangement by Share based Payment Award, Equity Instruments Other Than Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Expected to Vest, Exercisable, Aggregate Intrinsic ValueNo definition available.false2Intrinsic Value, Outstanding at end of period21false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValueopxa_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse130688130688USD$falsetruefalsexbrli:monetaryItemTypemonetaryShare based Compensation Arrangement by Share based Payment Award, Equity Instruments Other Than Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic ValueNo definition available.false2Intrinsic Value, Exercisable at end of the periodfalseWarrant Activity (Detail) (Warrants Attached to Debt, USD $)NoRoundingNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://www.opexatherapeutics.com/taxonomy/role/DisclosureWarrantActivity121